© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Cefmetazole Sodium first caught the attention of scientists looking for new answers to bacterial resistance in the late twentieth century. Researchers in Japan, facing waves of stubborn infections, looked past penicillin and older cephalosporins. They needed something with enough backbone to ward off gram-negative bacteria and not crumble under the pressure of beta-lactamase enzymes. The arrival of this cephamycin derivative meant hospitals gained one more weapon against hospital-acquired infections. Decades of clinical data, rigorous trials, and international use have turned it from an unfamiliar compound into a fixture in infectious disease wards across Asia.
Cefmetazole Sodium shows up in clinics as a white or nearly white crystalline powder. Doctors depend on it for its broad coverage: fighting off invaders like Escherichia coli, Klebsiella, and Bacteroides. It generally works as a second-generation cephamycin—offering an answer when first-line drugs fail. This edge draws from its ability to stare down certain antibiotic-destroying enzymes, keeping it useful even as resistance rates climb elsewhere. Pharmacies usually supply the drug in injectable form, making it handy in emergencies where oral antibiotics offer no relief.
The powder dissolves well in water, forming a clear solution for injection. Its melting point hangs around 190°C, resisting breakdown until subjected to high heat. Chemists marvel at its stability in light and slightly acidic environments, where other antibiotics fade out. The molecule features a beta-lactam ring fused to a six-membered dihydrothiazine ring, plus a methoxy group at position seven—responsible for its resistance to beta-lactamases. Its molecular weight floats near 505.46 g/mol. This structure gives it decent solubility and enough resilience to survive handling in a typical hospital setting.
Manufacturers focus on purity, usually exceeding 98%. Labels often specify not just the amount of active compound, but also residual solvents, pH range (generally 4.5-7.0), and particulate limits for the injectable forms—no room for error when patients rely on sterile, precise dosages. Each vial typically bears a batch number, critical for recalls or tracking adverse reactions, and includes strict storage instructions: keep away from moisture and heat to avoid decomposition. Health authorities demand clear expiration dates and unambiguous storage guidelines, minimizing risks from degraded or contaminated product.
Synthesizing cefmetazole sodium isn't a weekend project. The process involves multi-step organic syntheses, starting from 7-aminocephalosporanic acid. Chemists carefully protect the beta-lactam ring while building out the side chain through acylation reactions. Adding the methoxy group requires both skill and fancy reagents. Sodium hydroxide comes in at the end to neutralize and salt out the final product. Each batch goes through several rounds of crystallization, washing, and filtration to weed out impurities before vials and ampoules ever reach hospitals. Any slip-up can mean a batch that doesn't pass muster with regulatory watchdogs.
The molecule’s main draw lies with its methoxy side chain, which fends off beta-lactamases. In the lab, this means chemists can tweak parts of the molecule to test different activity profiles. Swapping out or adjusting side groups has given rise to a family of derivatives—some experimented with for higher activity or better stability. Though its beta-lactam ring can break down in harsh acid or base, under normal use, it hangs tough, delivering reliable results in clinical treatment. These characteristics keep it front and center for further research into derivatives and new antibiotics.
Pharmacies and researchers might call it by several names. Officially, it goes by cefmetazole sodium, but alternate handles appear in global literature: CMZ, ICM-133, and in Japan, "Sefmetazon." Some drug labels list it under brand names depending on the region or manufacturing company. This can create confusion for traveling patients or international caregivers. On regulatory paperwork, chemical abstracts and PubChem entries track every synonym, making it possible to dig up safety sheets or research in most databases.
No hospital takes injectable antibiotics lightly, especially one as potent as this. Healthcare workers follow protocols every step of the way: checking allergies, monitoring for cross-reactions with other antibiotics, and ensuring proper dilution before giving a dose. Because it's a cephalosporin, anyone with a known penicillin allergy needs extra care—although cross-reactivity seems lower here than with first-gen counterparts. Storage happens in well-monitored, temperature-controlled environments. Nurses and pharmacists watch for expiration dates, and local authorities keep an eye on batch quality to prevent contamination or degraded potency.
Doctors turn to this drug for complicated intra-abdominal infections, sepsis, urinary tract infections, and gynecological infections. One of its strengths is holding the line in surgical settings where bacteria change and adapt to standard drugs. Infectious disease specialists appreciate its broad spectrum, especially when facing organisms that laugh off other cephalosporins. In my own experience in hospitals, few antibiotics trigger so much debate among prescribing physicians as this one—balancing its robust power against the growing threat of resistance. Many hospitals have set up stewardship committees to make sure it gets used responsibly.
Laboratories remain active in improving cefmetazole sodium. Studies dig into ways to tweak the core structure for longer-lasting activity, easier dosing, or lower toxicity. Pharma companies look at delivery formats—like slow-release injectables or combinations with beta-lactamase inhibitors—to keep pace with evolving bacteria. Published studies dig deep into pharmacokinetics, examining how various patient populations process and clear the drug. Data from pharmacovigilance programs help researchers continually update safety profiles and guidelines, responding to real-world cases and keeping the drug on trusted formularies.
Every antibiotic comes with a risk of side effects. Early trials with cefmetazole sodium watched for everything from mild rashes to rare kidney problems. Animal toxicity studies shaped early dosing recommendations, finding levels where the benefits far outweighed the risks. In practice, most patients tolerate the drug well—though some run into headaches, gut upset, or signs of allergic reaction. Health agencies monitor signals for more severe reactions such as Stevens-Johnson syndrome or bone marrow suppression, though these events rarely crop up outside large surveillance cohorts.
The story of cefmetazole sodium is far from over. As resistance to older antibiotics picks up speed, researchers are forced to revisit compounds like this—mining old drugs for fresh answers to new threats. Combinations with adjuvant molecules, extended-release formulations, and even topical options all crowd the horizon. Hospitals, too, need to invest in quick diagnostic tools that match drugs to bugs within hours, not days—making sure patients get the right therapy with less trial and error. Focusing on careful stewardship while supporting innovation opens a path to keeping cefmetazole sodium useful long into the future. In many ways, its journey mirrors medicine’s larger quest: learning from the past, answering the needs of the present, and refusing to let up in the fight against microbial threats.
Cefmetazole Sodium steps in as a real player among antibiotics when people face tough bacterial infections. Hospitals and clinics often reach for this drug during times when older antibiotics don’t seem to do the job anymore. Doctors use it for stubborn urinary tract infections, bone infections, skin and soft tissue issues, and sometimes to keep infections at bay after surgery. It’s not a medicine picked for just anything—the choice comes after lab tests show bacteria that most common drugs can’t control.
This drug belongs to the cephamycin group, a close cousin of the cephalosporins, with a special knack for holding back the growth of Gram-negative bacteria. Gram-negative organisms include some of the most troublesome bugs found in hospitals, such as Escherichia coli and Klebsiella species. They don’t go down easy, especially for older adults and those with weaker immune systems.
From personal experience helping in a community clinic, doctors can spend hours looking at lab results, weighing the risk of resistance, and considering side effects before writing a prescription for Cefmetazole Sodium. Its effectiveness often means a patient can avoid complications or long hospital stays that come when bacteria gain the upper hand.
Relying on strong antibiotics like Cefmetazole Sodium brings real concerns. Overuse leads to resistance, which leaves patients even more vulnerable in the future. Some bacteria swap genes and learn how to sidestep this medication entirely. That’s why stewardship—choosing the right antibiotic only when truly needed—matters as much as scientific research.
Patients sometimes react to antibiotics, too. Side effects range from upset digestion to more serious allergic responses. Nobody should take this kind of drug without a clear prescription and careful follow-up from a healthcare worker. If the wrong bacteria get targeted, or if the course stops too soon, results can backfire.
Antibiotic resistance has grown into a genuine public health threat. A report in The Lancet shared that each year, hundreds of thousands of lives are cut short because common treatments stop working. Cefmetazole Sodium still handles many dangerous bugs, so it acts like a shield for the most at-risk patients. But new faces show up in clinics every year with bacteria that no medicine can defeat.
Staying careful means taking cultures before treatment, tracking resistance trends, and sharing drug information with patients so they understand why they’re given this medicine and how to use it. When doctors, patients, and labs all share responsibility, fewer people wind up fighting infections that no longer respond to standard drugs.
Hospitals can build stronger programs that track antibiotic choices and results. Pharmacists and nurses can double-check prescriptions, and keep an eye out for reactions. Policy makers can open doors for more research into new antibiotics, because the well-known drugs like Cefmetazole Sodium need backup for the next generation. Clear education for everyone in the community means people turn to antibiotics only when they’re truly needed, making sure these medications stay strong for those who need them most.
Cefmetazole sodium is a cephalosporin antibiotic mainly used in hospitals to tackle infections like urinary tract infections, intra-abdominal infections, and surgical site infections. Dosage isn’t random—doctors weigh in on the diagnosis, patient’s age, kidney function, and the seriousness of the infection before making a call. There’s no shortcut to getting this right. Giving too little risks treatment failure; too much raises the chance of side effects, like kidney or liver trouble. Both mistakes aren’t just numbers on a lab sheet—they can mean the difference between recovery and serious harm.
For most adults, the standard dose sits at 1 to 2 grams every 8 to 12 hours, given as an intravenous infusion. For people with mild infections, doctors stick to the lower end. With tougher bugs or deeper infections, they lean closer to 2 grams every 8 hours.
Elderly patients and those with weak kidneys can’t clear the drug as quickly, so the dose drops. Lab results—especially creatinine clearance—guide these adjustments. For someone with badly reduced kidney function, the dose might fall to half, and infusions get spaced out to avoid a buildup. Folks with healthy kidneys don’t run into this problem.
Pediatric dosing always calls for extra attention. Doctors use body weight to figure out the right amount—usually 40 to 80 mg/kg per day, divided into two or three doses. So, a 20 kg child might get between 800 to 1600 mg spread over the day. Children with kidney troubles need even closer monitoring, and their parents should always ask why a dose gets adjusted.
Cefmetazole sodium sees use before some surgeries to help block infections before they get started. A single dose before incision—1 or 2 grams for adults—is common in hospitals. Doctors don’t want to overuse antibiotics. More isn’t better; it’s about the right drug at the right time.
Getting the dosage wrong spells trouble. Too small a dose opens the door to antibiotic resistance, one of the top global health threats. Overshooting brings on headaches of its own: upset stomach, diarrhea, even allergic reactions. Blood tests and patient observation aren’t just medical routines—they catch problems before they turn serious. That’s why real-world monitoring matters as much as lab guidelines.
Doctors and pharmacists owe it to patients to talk through antibiotic plans. It’s smart to ask: Why this dose? How long do I take it? Are there signs I should watch for? Patients trusting the process helps, but they should always speak up with any side effects or confusion. The best outcomes come from team effort, not blind trust.
The story of cefmetazole sodium’s dosage underlines why expertise counts in prescribing antibiotics. Hospitals use antibiotic stewardship programs for a reason—these teams keep tabs on use, limit mistakes, and help fight drug resistance. Patients stay safer, bacteria stay vulnerable a bit longer, and medicine does its job.
Doctors turn to Cefmetazole Sodium when fighting tough infections. This antibiotic, used in hospitals and clinics, tackles bacterial strains that laugh off more basic medicine. Folks with urinary tract infections, pneumonia, or skin bugs may have come across a doctor recommending this drug. Antibiotics never come free of charge, though—side effects remain part of the package. Knowing what could happen makes all the difference in getting treated safely.
Stomach issues strike the hardest for most people. I’ve seen friends start complaining a few days in: nausea, vomiting, belly pains, and even diarrhea. That gut discomfort doesn’t always let up, so some cut their course short or need other medicine to get by. A 2023 review published in the British Journal of Clinical Pharmacology points out that around 15% of folks treated with similar antibiotics develop mild to moderate stomach issues. Too many forget that medicines like Cefmetazole can upset the balance of bacteria in your digestive tract.
Allergy risk weighs heavy with any cephalosporin. Some people break out in rashes, start itching, or develop swelling in the face and throat—symptoms that deserve urgent attention. My cousin ended up in the ER thanks to an allergic reaction to a related antibiotic, so I always tell people to speak up about allergies before starting anything new. About one in a hundred shows a true allergy, and folks with a penicillin allergy have a higher risk.
Cefmetazole can affect organs, even if you don’t notice right away. Your liver works overtime clearing out medication, and sometimes blood tests catch signals of mild damage—things like elevated liver enzymes. This impact usually reverses after stopping the drug, but it’s wise to watch those numbers, especially for people with chronic liver or kidney issues. In serious cases, kidney function drops, which can lead to trouble clearing the medicine and greater side effects.
Even though blood-related issues stay rare, they can still create big problems. People taking Cefmetazole can see shifts in their blood counts, such as lower platelets or white cells, which help fight infection and prevent bleeding. I know a middle-aged man who needed a different antibiotic after routine bloodwork picked up on falling platelets. From then on, his care team watched his numbers more closely. The risk grows with longer courses or if someone takes other medicine that affects the bone marrow.
Using antibiotics changes the mix of bacteria in your body. Doctors talk about superinfections all the time—Clostridioides difficile (C. diff) being the one that makes headlines for causing painful, dangerous diarrhea. This risk goes up the longer someone uses broad-spectrum antibiotics like Cefmetazole. My work in healthcare showed how easily hospital outbreaks start from unchecked antibiotic use, and why hospitals now steer patients toward narrow-spectrum drugs unless there’s no other way.
Avoiding trouble means listening to your body, talking honestly with your doctor, and getting regular checkups during any antibiotic course. If you start feeling sick, rashy, or run into stomach trouble that doesn’t go away, make noise about it. Labs and follow-ups help catch early signs of rare problems. Taking only what’s needed—no more, no less—cuts the risk of serious side effects. Relying on the most effective, least risky antibiotic for each situation keeps more folks out of harm’s way and slows the march of resistance in hospitals and communities everywhere.
Cefmetazole sodium gets used in hospitals for some tough infections, especially when other antibiotics have stopped working. Upright science stands behind it: it’s a second-generation cephalosporin, trusted for years by infectious disease doctors. In my own practice, I’ve watched it beat down complicated urinary tract and intra-abdominal infections. But no drug arrives free of trade-offs, and skipping the small print on this antibiotic can bring trouble.
If someone carries a history of allergies to penicillins or other cephalosporins, I flag their chart before suggesting cefmetazole. That’s not split-hairs caution; severe allergic reactions, including anaphylaxis, don’t give a second chance. Studies from Japan and Europe estimate cross-reactivity rates as high as ten percent. Any swelling, hives, or trouble with breathing in the past gets a hard stop sign.
Kidney function makes a difference with every dose. This drug clears the body through the kidneys. Patients living with chronic kidney disease or very old age, common in my patient list, hold onto this antibiotic longer than intended. That buildup risks neurotoxicity and seizures, something I’ve seen more than once in my training. Always adjust the dose when the kidneys can’t filter fast enough. Lab work before and during therapy helps dodge complications.
Mixing cefmetazole with certain medications doesn’t always sit well. It can tangle up with blood thinners like warfarin, shooting INR levels skyward and leading to unexpected bleeding. Older patients, already taking a handful of daily pills, face the highest risk.
Alcohol is a bigger issue with this specific antibiotic compared to others in its class. The so-called disulfiram-like reaction — nausea, chest pain, vomiting, pounding heart — can hit hard if someone drinks alcohol during treatment, sometimes even after stopping the drug. I’ve seen folks end up in the ER, embarrassed by the reaction. Sharing this warning openly has kept a lot of my patients out of trouble.
In newborns or pregnant people, cefmetazole generally gets pushed aside. Newborn livers and kidneys don’t process the drug efficiently. There’s little hard evidence on birth defects, but most guidelines push for other antibiotics unless the pros clearly beat the cons.
Smart use starts by keeping allergies front and center. Double-check old hospital records, talk to the patient, and don’t ignore vague past reactions. Hospitals need clear guidelines for dose adjustment in kidney problems, and frequent bloodwork to back that up.
Doctors, nurses, pharmacists, and patients themselves should talk openly about any drugs or supplements taken. Patients with limited health literacy deserve extra time and better explanations on what can go wrong with certain mixes. Every prescription deserves a clear warning about not drinking alcohol until days after the antibiotic finishes.
Public health still leans heavily on older antibiotics as resistance spreads. The wiser we get at picking out problems early, the longer these medicines will last. Cefmetazole sodium rewards vigilance — sloppy shortcuts punish everyone. From personal experience and digging through the studies, listening to patients and checking every box beats rushing any day.
Cefmetazole sodium comes with its own list of storage expectations, and ignoring these can lead to trouble for patients and clinics. The recommended storage temperature hovers below 25°C — or about 77°F for those used to Fahrenheit. Storing this antibiotic at room temperature away from excess heat or freezing conditions keeps its power intact. If the vial sits next to a radiator, in direct sunlight, or in a fridge that fluctuates between freezing and warm, its chemical stability starts to take a hit.
Humidity may seem harmless, but it quietly chips away at powders and injectable drugs. Exposing cefmetazole sodium to moisture can cause clumping, discoloration, or even a total loss of activity. I’ve seen hospital storerooms in the middle of summer where air-conditioning fails — within weeks, sensitive meds start to degrade, including antibiotics like this one. Keeping vials sealed tight, using desiccant packs when feasible, and double-checking storage areas in the hotter months go a long way.
Leaving medication on a shelf doesn’t guarantee safety. Pharmacies and clinics use dedicated medicine cabinets or fridges with temperature monitoring for just this reason. If there’s a power cut or air-conditioning breaks, having a backup plan protects not just inventory but also patient care down the line. At home, don’t stash vials in bathroom medicine cabinets. Moisture and heat build up quickly after a shower. A bedroom drawer away from windows offers much more stability.
Some antibiotics break down faster with light exposure. Although cefmetazole sodium vials often use amber glass, direct sunlight still causes trouble. I learned this early in my career when an entire batch had to be tossed after sitting on a sunny pharmacy counter for just a day. Avoid storing any injectable antibiotic where sunlight pours in, especially next to windows or glass-fronted cabinets.
A drug’s shelf life is not a suggestion. Using expired cefmetazole sodium risks reduced activity and possible harm to patients. Each vial lists a clear date, but that assumes proper storage conditions. If the powder looks odd, clumped, or discolored—trust your eyes and ears and get a replacement. Real-world experience always beats textbook advice here: question any stock that feels off and involve a pharmacist before use.
Pharmacies and care facilities that set clear routines around drug management see fewer problems with antibiotic effectiveness. Training staff on what “good storage” looks like—temperature charts on the wall, regular inventory checks, using alarmed fridges—pays off fast. Putting the responsibility front and center reduces waste and builds trust with prescribers and patients. I’ve seen clinics where every vial lasts its full shelf life; the common thread is always organized, consistent storage.
Not everyone has access to industrial refrigerators or backup generators. At home, storing cefmetazole sodium means picking a closet or drawer outside the bathroom and kitchen—places with the least chance of temperature swings or humidity. Small thermometer strips can help spot problems. Some community health programs hand these out to patients who need to store sensitive meds at home.
Proper storage sounds simple; in reality, it takes daily checks and a bit of caution. Every dose counts. Keeping cefmetazole sodium fresh and strong helps beat infections and avoids costly mistakes. Safety routines in storage don’t just protect medications—they support every person who relies on them.
| Names | |
| Preferred IUPAC name | Sodium (6R,7S)-3-[(acetoxy)methyl]-8-oxo-7-[2-(1-methyltetrazol-5-ylsulfanyl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
| Other names |
CMZ Cefmetazole monosodium salt Sodium cefmetazole |
| Pronunciation | /sefˈmɛtəzoʊl ˈsoʊdiəm/ |
| Identifiers | |
| CAS Number | 68401-82-1 |
| Beilstein Reference | 11337997 |
| ChEBI | CHEBI:3493 |
| ChEMBL | CHEMBL2107736 |
| ChemSpider | 163651 |
| DrugBank | DB00268 |
| ECHA InfoCard | 100.037.353 |
| EC Number | 25613-53-4 |
| Gmelin Reference | 915321 |
| KEGG | D07610 |
| MeSH | D002493 |
| PubChem CID | 656608 |
| RTECS number | XZ2170000 |
| UNII | Y59JL23L1X |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID0029411 |
| Properties | |
| Chemical formula | C15H16N7NaO5S3 |
| Molar mass | 475.37 g/mol |
| Appearance | White to light yellow crystalline powder |
| Odor | Odorless |
| Density | 1.64 g/cm³ |
| Solubility in water | Very soluble in water |
| log P | -2.3 |
| Acidity (pKa) | 2.6 |
| Basicity (pKb) | 8.3 |
| Dipole moment | 5.76 D |
| Pharmacology | |
| ATC code | J01DD11 |
| Hazards | |
| Main hazards | Causes eye, skin, and respiratory tract irritation. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS05, GHS07 |
| Signal word | Warning |
| Hazard statements | Hazard statements: Causes serious eye irritation. May cause respiratory irritation. |
| Precautionary statements | Keep container tightly closed. Store in a dry place. Store in a closed container. |
| NFPA 704 (fire diamond) | 1-2-0-OX |
| Explosive limits | Explosive limits: Non-explosive |
| Lethal dose or concentration | LD50 (intravenous, mouse): 1260 mg/kg |
| LD50 (median dose) | LD50 (median dose): Mouse intravenous LD50 = 2220 mg/kg |
| PEL (Permissible) | Not Established |
| REL (Recommended) | 2 g/day |
| Related compounds | |
| Related compounds |
Cefotetan Cefoxitin Cefminox |
